BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Freitag J, Shah K, Wickham J, Tenen A. Effect of autologous adipose-derived mesenchymal stem cell therapy in combination with autologous platelet-rich plasma in the treatment of elbow tendinopathy. BMJ Case Rep 2020;13:e234592. [PMID: 32606116 DOI: 10.1136/bcr-2020-234592] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Senesi L, De Francesco F, Marchesini A, Pangrazi PP, Bertolini M, Riccio V, Riccio M. Efficacy of Adipose-Derived Mesenchymal Stem Cells and Stromal Vascular Fraction Alone and Combined to Biomaterials in Tendinopathy or Tendon Injury: Systematic Review of Current Concepts. Medicina (Kaunas) 2023;59. [PMID: 36837474 DOI: 10.3390/medicina59020273] [Reference Citation Analysis]
2 Hart DA, Ahmed AS, Ackermann P. Optimizing repair of tendon ruptures and chronic tendinopathies: Integrating the use of biomarkers with biological interventions to improve patient outcomes and clinical trial design. Front Sports Act Living 2022;4:1081129. [PMID: 36685063 DOI: 10.3389/fspor.2022.1081129] [Reference Citation Analysis]
3 Mirghaderi SP, Valizadeh Z, Shadman K, Lafosse T, Oryadi-Zanjani L, Yekaninejad MS, Nabian MH. Cell therapy efficacy and safety in treating tendon disorders: a systemic review of clinical studies. J Exp Orthop 2022;9:85. [PMID: 36042110 DOI: 10.1186/s40634-022-00520-9] [Reference Citation Analysis]
4 Lee S, Chae DS, Song BW, Lim S, Kim SW, Kim IK, Hwang KC. ADSC-Based Cell Therapies for Musculoskeletal Disorders: A Review of Recent Clinical Trials. Int J Mol Sci 2021;22:10586. [PMID: 34638927 DOI: 10.3390/ijms221910586] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]